Skip to main content

HB 512 — Kentucky

AN ACT relating to prescription drugs.

Introduced 2026RS session House

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

Amend KRS 304.17A-164 to define and redefine terms; establish cost-sharing requirements for prescription drugs; require rebates to be passed through; establish confidentiality requirements for the rebate information; create a new section of KRS 365.880 to 365.900 to provide that the actual amount of rebates received is a trade secret; provide that compliance with prescription drug cost-sharing and rebate requirements shall not be in violation of the Uniform Trade Secrets Act; amend KRS 304.17C-125, 304.38A-115, 18A.225, and 164.2871 to apply the cost-sharing and rebate requirements for prescription drugs to limited health service benefit plans, limited health service organizations, the state employee health plan, and self-insured employer group health plans provided by the governing board of a state postsecondary education institution; apply provisions to health plans issued or renewed on or after January 1, 2027; EFFECTIVE January 1, 2027.

Official abstract, as published by the legislature.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: K. Moser, K. Banta, S. Bratcher, J. Calloway, S. Dietz, P. Griffee, V. Grossl, T. Hampton, M. Hart, J. Nemes, M. Proctor

History

  1. Introduced, completed
  2. Passed House, in progress
  3. Passed Senate, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. House introduced in House Milestone
  2. House to Committee on Committees (H)
  3. House to Banking & Insurance (H) Latest

Source: Open States. Last checked November 10, 2026. How we keep this accurate ›